Management Quality -- 8/10
Allison Transmission management earns a strong 8/10 on exceptional margin discipline through a
cyclical downturn (37.5% EBITDA margin with revenue down 7%), a deep bench led by Graziosi and
Bohley with 17+ years together, and best-in-class capital allocation (63%+ of shares repurchased
since IPO). 11 promises tracked with strong delivery across defense growth, pricing, and capital
returns. The score is held below 9 by the FY2025 initial revenue miss (~$240M below midpoint),
the significant integration risk of the $2.7B Dana Off-Highway acquisition, and the lower-margin
profile of the acquired business.
Weight: 20%
CEO
Dave Graziosi
CEO since 2018 | 20+ years at Allison
Promise Delivery
11 tracked, strong
6 beat/met, 2 in progress, 1 miss (macro), 2 partial
FY2025 EBITDA Margin
37.5%
+140bps YoY despite 7% revenue decline
Shares Repurchased
63%+ since IPO
6 consecutive dividend increases
Leadership team
Dave Graziosi -- Chair, President, and CEO
CEO since 2018 with 20+ years at Allison, promoted from COO/CFO. Deep institutional
knowledge across the entire business. Added President title in 2025. The Graziosi-Bohley
partnership spans 17+ years, creating strong continuity at the top. Operationally
focused with a measured communication style -- rarely promotional.
Fred Bohley -- COO, President Transmission BU
CFO since ~2017, added COO title mid-2024. 17+ years working with Graziosi. Now leads
the Transmission business unit post-Dana acquisition. The CFO succession to Scott Mell
(joined Q1 2025, ~30 years experience) was planned and orderly -- no disruption.
Craig Price joined Jan 2026 to lead the acquired Dana Off-Highway segment.
Promise vs. delivery tracker (11 promises)
| When Promised | Promise | Evidence | Grade |
|---|---|---|---|
| Q3 2024 | FY2024 revenue guidance raise | Guided $3,135M-$3,215M; delivered $3,225M (+$10M above high end) | BEAT |
| Q3 2024 | FY2024 adjusted EBITDA guidance | Guided $1,115M-$1,175M; delivered $1,165M (near high end) | MET |
| Ongoing | Defense: $100M incremental annual revenue | $267M in FY2025 vs $212M FY2024 vs ~$165M base. Confirmed fully realized on Q4 2025 call | ACHIEVED |
| Ongoing | Wide-body dump: $100M incremental revenue | ~$50M realized by end 2024 (~half). New 6000 series, TerraTran driving continued progress | IN PROGRESS |
| Q4 2024 | FY2025 initial revenue guidance | Guided $3,200M-$3,300M; actual $3,010M. Guided down methodically each quarter | MISSED |
| Q4 2024 | FY2025 EBITDA margin expansion | Guided 80bps expansion; delivered +140bps to 37.5% despite 7% revenue decline | BEAT |
| Q4 2024 | Pricing: 400bps across enterprise in 2025 | Achieved >450bps for full year (~$130M+ in price realization) | BEAT |
| Q3 2024 | India capacity expansion: operational 2026 | ~$100M investment confirmed operational per Q4 2025 call; ramping to full capacity 2027 | ON TRACK |
| Ongoing | Share repurchase program | FY2025: $328M repurchased (4% of shares); 6th consecutive dividend increase to $0.27/qtr | DELIVERED |
| Q2 2025 | Dana Off-Highway: close late Q4 2025 | $2.7B purchase price. Closed Jan 1, 2026 (~1 month late). No synergies in 2026 guide | LARGELY MET |
| Ongoing | Outside NA On-Highway: double-digit annual growth | FY2025 $507M (record, +3% YoY) but growth rate below double-digit target | PARTIAL |
11 promises tracked. 6 beat or met, 2 in progress/on track, 2 partially met, 1 miss on initial
FY2025 revenue (macro-driven, guided down transparently). EBITDA margin and pricing targets
consistently exceeded. Defense growth fully delivered on the $100M incremental target.
Source: Daloopa, earnings call transcripts Q3 2024 - Q4 2025.
FY2025 revenue guidance evolution (standalone Allison Transmission)
| Quarter | Revenue Guide (Midpoint) | Change | Notes |
|---|---|---|---|
| Q4 2024 (initial) | $3,250M | -- | Initial guide Feb 2025 |
| Q1 2025 | $3,250M | No change | Reaffirmed |
| Q2 2025 | $3,125M | -$125M | NA On-Highway weakness |
| Q3 2025 | $3,000M | -$125M | OEM build rate cuts, tariff uncertainty |
| FY2025 Actual | $3,010M | Met revised guide | ~$240M below initial midpoint |
Management was methodical in guiding down as NA On-Highway weakened through H2 2025. They were
transparent about causes (OEM build rate cuts, medium-duty softness, tariff/emissions uncertainty).
Critically, they expanded EBITDA margins throughout the downturn -- demonstrating cost discipline
over revenue chasing. The initial miss was driven by external factors, not operational failures.
Operational execution strengths
Margin expansion through downturn
Pricing power
Secured >450bps of price in 2025 through new LTAs (vs 400bps target). LTAs leaned
shorter duration with positive pricing in every year. Commodity pass-throughs (2/3 steel,
80% aluminum) protect margins. Future LTA pricing will be "quite a bit higher" than
historical 50-100bps per management.
Defense growth execution
Defense revenue grew from ~$165M (2023 est.) to
$267M
in FY2025 -- 26% CAGR. Achieved the $100M incremental target. Major wins: $80M Abrams
X1100, India FICV selection, Poland Borsuk, Turkey Korkut, eGen Force Phase 2 NGET.
International defense pipeline is deep.
Strategic M&A -- Dana Off-Highway
$2.7B acquisition at 6.8x EBITDA (5.2x including $120M run-rate synergies). Nearly doubles
revenue, adds global footprint in 25 countries, diversifies into ag/construction/mining.
Accretive in year 1. Prudent approach: no synergies assumed in 2026 guide. Net leverage
at 1.33x entering the deal.
Capital allocation
Shareholder returns: 63%+ of shares repurchased since IPO. FY2025: $328M
repurchased (4% of float). 6 consecutive dividend increases to $0.27/quarter. Buybacks
executed at ~$88 average in FY2024 (stock now ~$117). This is best-in-class capital return
for an industrial company.
Balance sheet discipline: Maintained $900M+ cash while completing the $2.7B Dana acquisition. Net leverage at 1.33x entering the deal, targeting 2x near-term post-Dana. No excessive leverage risk.
Organic investment: ~$100M India capacity expansion on track (operational 2026, full production 2027). Doubles manufacturing footprint. Electrification investments have been "meaningfully but measured" -- $29M impairment in Q4 2025 on EV investments, but smaller than peers who over-invested.
Balance sheet discipline: Maintained $900M+ cash while completing the $2.7B Dana acquisition. Net leverage at 1.33x entering the deal, targeting 2x near-term post-Dana. No excessive leverage risk.
Organic investment: ~$100M India capacity expansion on track (operational 2026, full production 2027). Doubles manufacturing footprint. Electrification investments have been "meaningfully but measured" -- $29M impairment in Q4 2025 on EV investments, but smaller than peers who over-invested.
Strengths and concerns
Strengths
1. Elite margin management. 37.5% EBITDA margin with revenue down 7%.
Expanded margins 140bps through a downturn -- demonstrates genuine pricing power and
cost discipline, not just cyclical leverage.
2. Defense growth delivered. $100M incremental revenue target fully achieved. 26% CAGR from ~$165M to $267M. Deep international pipeline with major contract wins across multiple platforms and geographies.
3. Best-in-class capital allocation. 63%+ shares repurchased since IPO, 6 consecutive dividend increases, buybacks at $88 avg (now ~$117). Disciplined and consistently shareholder-aligned.
4. Long-tenured, operationally deep team. Graziosi + Bohley = 17+ years together. Planned CFO succession. No sudden departures or governance red flags.
5. Transparent guidance process. Guided down methodically through H2 2025. Never sandbagged then missed. Conservative synergy assumptions on Dana deal.
2. Defense growth delivered. $100M incremental revenue target fully achieved. 26% CAGR from ~$165M to $267M. Deep international pipeline with major contract wins across multiple platforms and geographies.
3. Best-in-class capital allocation. 63%+ shares repurchased since IPO, 6 consecutive dividend increases, buybacks at $88 avg (now ~$117). Disciplined and consistently shareholder-aligned.
4. Long-tenured, operationally deep team. Graziosi + Bohley = 17+ years together. Planned CFO succession. No sudden departures or governance red flags.
5. Transparent guidance process. Guided down methodically through H2 2025. Never sandbagged then missed. Conservative synergy assumptions on Dana deal.
Concerns
1. FY2025 initial revenue miss. ~$240M below initial midpoint. Management
did not foresee the severity of H2 2025 On-Highway weakness at the February guide.
Macro-driven, but still a forecasting miss.
2. Dana integration risk. $2.7B acquisition nearly doubles the business. Off-Highway margins are ~11-12% EBITDA initially vs 37.5% for legacy Allison. No synergies captured yet. Major execution risk ahead.
3. Outside NA growth below target. Stated double-digit annual growth target, but FY2025 delivered only +3% YoY ($507M vs $493M). Records set but growth rate consistently below the stated ambition.
4. EV impairment. $29M write-down on electrification investments in Q4 2025. Small, but shows some capital deployed into a thesis that did not fully materialize.
5. Promotional outlier. Bohley aspirational "$200+ stock in 3 years" comment (Q2 2025) is atypical for this otherwise measured team. Worth monitoring for tone drift.
2. Dana integration risk. $2.7B acquisition nearly doubles the business. Off-Highway margins are ~11-12% EBITDA initially vs 37.5% for legacy Allison. No synergies captured yet. Major execution risk ahead.
3. Outside NA growth below target. Stated double-digit annual growth target, but FY2025 delivered only +3% YoY ($507M vs $493M). Records set but growth rate consistently below the stated ambition.
4. EV impairment. $29M write-down on electrification investments in Q4 2025. Small, but shows some capital deployed into a thesis that did not fully materialize.
5. Promotional outlier. Bohley aspirational "$200+ stock in 3 years" comment (Q2 2025) is atypical for this otherwise measured team. Worth monitoring for tone drift.
Red flags check
| Flag | Present? | Detail |
|---|---|---|
| CEO/CFO turnover | No | Graziosi CEO since 2018; CFO transition (Bohley to Mell) was planned and orderly |
| Missed guidance repeatedly | Minor | Initial FY2025 guide missed by ~$240M on revenue, but managed down transparently; EBITDA margin beat |
| Aggressive accounting | No | Conservative guidance approach; no synergies in 2026 guide despite $120M target |
| Insider selling concerns | No | No unusual patterns noted in transcripts |
| Excessive leverage | No | 1.33x net leverage pre-deal; targeting 2x near-term post-Dana |
| Related party transactions | No | None flagged |
| Promotional language | Minor | Bohley $200+ stock comment is atypical; otherwise management is measured and data-driven |
| EV/electrification overpromise | Minor | $29M impairment in Q4 2025; however, historically measured on EV -- invested less than peers |
| Capital misallocation | No | Buybacks at $88 avg in 2024 (stock now ~$117); dividend growth; organic investment well-funded |
| Board/governance concerns | No | None flagged |
Score rationale
8/10. Allison management earns a strong score on (a) exceptional margin management
through a cyclical downturn -- 37.5% EBITDA margin with revenue down 7%, (b) strong promise
delivery on defense growth ($100M incremental target achieved, 26% CAGR) and pricing (>450bps
vs 400bps target), (c) best-in-class capital allocation for an industrial (63%+ shares
repurchased since IPO, 6 consecutive dividend increases), and (d) a long-tenured, operationally
deep leadership team with planned succession.
Why not 9+: (1) FY2025 initial revenue guide missed by ~$240M -- even if macro-driven, the team did not anticipate H2 On-Highway severity at initial guide; (2) Dana Off-Highway integration ($2.7B, nearly doubling the business) is a significant execution risk with lower initial margins (~11-12% vs 37.5%); (3) Outside NA growth has consistently fallen short of the stated double-digit annual target.
What would move this to 9+: Dana synergies materialize on schedule ($120M run-rate target). Off-Highway margins improve toward mid-teens. FY2026 guidance accuracy improves. Outside NA growth reaccelerates toward double digits. Integration proceeds without operational disruption to the legacy Transmission business.
Why not 9+: (1) FY2025 initial revenue guide missed by ~$240M -- even if macro-driven, the team did not anticipate H2 On-Highway severity at initial guide; (2) Dana Off-Highway integration ($2.7B, nearly doubling the business) is a significant execution risk with lower initial margins (~11-12% vs 37.5%); (3) Outside NA growth has consistently fallen short of the stated double-digit annual target.
What would move this to 9+: Dana synergies materialize on schedule ($120M run-rate target). Off-Highway margins improve toward mid-teens. FY2026 guidance accuracy improves. Outside NA growth reaccelerates toward double digits. Integration proceeds without operational disruption to the legacy Transmission business.
Data sourced from Daloopa and earnings call transcripts Q3 2024 - Q4 2025.